AstraZeneca COVID-19 vaccine likely to protect for a year - CEO
BRUSSELS (Reuters) - AstraZeneca's potential coronavirus vaccine <AZN.L> is expected to protect against COVID-19 infection for about a year, the company's managing director told a Belgian radio station on Tuesday.
The British pharmaceutical company has already started trials on people developed by Oxford University. A Phase I study in the UK is expected to end soon and a Phase III study has already started, Pascal Soriot told Bel RTL.
"We believe it will protect for about a year," said Soriot.
AstraZeneca announced on Saturday that it had signed contracts with France, Germany, Italy and the Netherlands for the delivery of up to 400 million doses of the potential vaccine to the European Union.
Agreements have also been made with the United Kingdom and the United States.
"If everything goes well, we will have the results of the clinical studies in August / September. We will produce in parallel. We will be able to deliver from October if everything goes well," said Soriot.
(Reporting by Philip Blenkinsop; Editing by Jason Neely)
Watch the latest videos from Yahoo UK
You should check here to buy the best price guaranteed products.
Assist of the Night: Luka Doncic
Fire destroys 5 buildings on Massachusetts coast
J.J. Watt calls first season in Arizona a “massive failure” for the Cardinals
NCIS - Baby Steps
Smashed antiques, ripped oil paintings and the perils of letting a film crew into your stately home
Cam Akers praying for Budda Baker after scary hit: ‘I didn’t know he was hurt after the play’